Protagonist Therapeutics (PTGX) Reports Q4 Loss, Tops Revenue Estimates
1/3 00:15
Protagonist Therapeutics (PTGX) came out with a quarterly loss of $0.77 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to loss of $0.48 per share a year ago. These figures are adjusted for non-recurring items....